Promoter entity Roshan Dealmark Private Limited has sold 1,400,000 equity shares of Tavexia Lifecare Ltd through an on-market transaction. Following this sale on September 7, 2026, the promoter group's stake in the company has decreased...
Biocon has signed a 10-year partnership with Bahiafarma and Bionovis to supply Pertuzumab in Brazil. The consortium secured 100% allocation under Brazil's Productive Development Partnership program, giving it exclusive access to the publ...
Orchid Pharma Ltd will seek shareholder approval for up to Rs 400 crore of FY27 purchases from Otsuka Chemicals (India) Private Limited, a related party and the company's only approved source for GCLE, a key raw material. The September 2...
ANG Lifesciences India reported a net loss for FY26 as revenue stagnated. The company faces significant financial distress, including Rs 13.44 crore in bank defaults, irregular statutory payments, and ongoing audit concerns regarding com...
Novelix Pharmaceuticals reported a strong FY 2025-26 with revenue rising over 330% to Rs 132.31 crore. Net profit improved significantly to Rs 2.56 crore, up from Rs 0.08 crore in the previous year. The company confirmed an unmodified au...
Alpa Laboratories reported a challenging fiscal year 2025-26, with revenue and profit declining due to pricing pressures and soft demand. The company opted to preserve cash by skipping dividends to fund future growth. Key developments in...
Asston Pharmaceuticals reported a 23.33% rise in total income for FY26 but saw net profit remain nearly flat due to a 31% surge in operational costs. The company recently commissioned its Unit II plant and is navigating a major equity di...
Astal Laboratories reported strong FY26 revenue growth to Rs 250.37 crore, marking a significant scaling phase. While consolidated profits improved, the company opted to retain earnings, skipping dividends to fund a planned 50% manufactu...
Aayush Wellness reports a strong FY26 with revenue hitting Rs 158.09 crore, up 115% year-on-year. While net profit grew by 18% to Rs 3.98 crore, margins faced pressure due to heavy investments in the new Aayush Labs diagnostic platform a...
Bal Pharma has allotted 10 lakh convertible warrants to promoter Shailesh Siroya at Rs 84 per warrant. The company has received 25% of the total Rs 8.4 crore consideration upfront. These warrants can be converted into equity shares over...
Parmax Pharma reported a sharp 57% decline in revenue to Rs 12.11 crore for FY26, with net losses widening to Rs 4.16 crore. The company faces significant regulatory scrutiny after statutory auditors flagged violations regarding deposit...
Metropolis Healthcare is restructuring its subsidiary, Metropolis Quality Solutions, by bringing in Medsource Ozone Biomedicals and Dr. Puneet Kumar Nigam as strategic partners. The deal involves a share subscription and shareholder agre...
Fischer Medical Ventures reported strong FY26 results with revenue jumping to Rs 308.58 crore and a net profit of Rs 31.07 crore. The company is scaling its medical imaging and diagnostics business, supported by key product launches like...
Concord Drugs Limited reported a strong FY 2025-26, with standalone revenue doubling to Rs 75.85 crore and profit after tax rising significantly to Rs 1.04 crore. The company strengthened its balance sheet through a preferential allotmen...
Soni Medicare Limited reported a net loss of Rs 2.71 crore for FY26, widening from Rs 0.19 crore in the previous fiscal. Revenue declined to Rs 24.71 crore from Rs 29.84 crore. The management has initiated an operational reset to boost p...